Acetylsalicylic Acid (Aspirin, ASA) Flashcards
1
Q
General
A
- Platelet inhibitor & antithrombotic medication
- Given to PTs w/ cardiac chest pain during Primary Survey
- Considered a critical intervention
- ONLY medication EMR may administer without baseline set of vitals
2
Q
Classification
A
Platelet inhibitor/anti-inflammatory
3
Q
Action
A
Blocks platelet aggregation & vasoconstriction
4
Q
Indications
A
Chest pain or atypical symptoms suggestive of cardiac ischemia & myocardial infarction
5
Q
Contraindications - Functional inquiry
A
- Asthma Exacerbation
- Ask PT if their asthma has ever been exacerbated by taking NSAIDS (e.g. ibuprofen, Naproxen) - Allergy / Hypersensitivity
- Ask PT if they have a hypersensitivity to Aspirin or other NSAIDS - Pediatric
- Pediatric w/ viral illness contraindicated
- Chest pain in children is unlikely to be ischemic in nature, as such ASA contraindicated unless rare specific ischemic cardiac history - Dose
- PT may not exceed 162mg w/in a 12 hr period - Acute Bleed
- Lood for any signs or symptoms of an acute bleed including signs & symptoms of CVA or history of recent head trauma (brain bleed)
6
Q
Contraindications - Physical Assessment
A
None
7
Q
Cautions - Functional Inquiry
A
- Pregnancy
- Ask PT about possibility of pregnancy - Recent internal bleeding
- Ask abt blood in vomit/stool (GI bleed) - Bleeding Disorders
- Review history - Anticoagulants
- Review meds for PT currently taking anticoagulants - Surgery
- Ask abt recent major surgery (heart, vascular, abdominal, angioplasty/angiograms)
8
Q
Cautions - Physical Assessment
A
- Recent Internal Bleeding
- Assess for S&S of internal hemorrhaging (Blood in vomit/stool, S&S of shock, rigid abdomen, bruising around navel/flank)
- Assess for head injuries
- S&S of stroke
- S&S of intracranial pressure (increased BP, irregular breathing & bradycardia, unequal pupils DLOC) - Surgery
- Assess for scars indicating recent surgery
9
Q
Side effects
A
- Respiratory: wheezing
- GI: Heartburn, nausea & vomiting
- ASA has been linked to Reye’s syndrome in children w/ viral symptoms
10
Q
Dosage
A
160-162 mg in a 12 hr period
11
Q
Routes
A
PO
12
Q
Onset, Duration
A
- Onset: 1 hr or 20 mins if chewed
- Peak: 1-2 hrs
- Duration: 4-6 hrs; platelet inhibitory effects last lifetime of platelet
- Half Life: 3hrs (low dose)